Century Therapeutics, Inc. (IPSC)

Century Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-126.57	-136.67	-130.93	-95.82	-53.58
Depreciation & Amortization	13.3	13.04	8.44	3.75	1.4
Other Amortization	-	0.09	0.3	0.31	0.09
Asset Writedown & Restructuring Costs	4.33	16.37	-	-	4.72
Loss (Gain) From Sale of Investments	-4.81	-3.98	-	-	-
Stock-Based Compensation	12.69	14.62	10.67	4.73	0.88
Other Operating Activities	0.2	-1.2	1.63	0.83	0.35
Change in Accounts Payable	-1.47	-2.36	-4.79	-1.85	2.06
Change in Unearned Revenue	-6.59	-2.24	117.99	-	-
Change in Other Net Operating Assets	-1.22	13.98	10.75	-0.95	2.8
Operating Cash Flow	-110.14	-88.35	14.05	-89	-41.27
Capital Expenditures	-0.15	-13.74	-30.6	-44.97	-9.83
Cash Acquisitions	-9.61	-	-	-	-4.72
Investment in Securities	57.24	74.87	17.48	-253.37	-8.21
Investing Cash Flow	47.48	61.13	-13.13	-298.34	-22.76
Long-Term Debt Issued	-	-	-	-	9.73
Long-Term Debt Repaid	-	-10.24	-	-	-
Net Debt Issued (Repaid)	-	-10.24	-	-	9.73
Issuance of Common Stock	74.56	0.52	27.16	277.07	38.1
Other Financing Activities	-	-	-	-18.92	-0.14
Financing Cash Flow	74.56	-9.73	27.16	417.77	47.69
Net Cash Flow	11.91	-36.94	28.08	30.43	-16.34
Free Cash Flow	-110.29	-102.08	-16.55	-133.97	-51.09
Free Cash Flow Margin	-1673.84%	-4567.52%	-318.37%	-	-
Free Cash Flow Per Share	-1.40	-1.72	-0.29	-4.14	-6.83
Cash Interest Paid	-	0.59	1.1	0.97	0.21
Cash Income Tax Paid	0.5	2.52	-	0.01	-
Levered Free Cash Flow	49.44	-71.09	-79.59	-96.45	-30.01
Unlevered Free Cash Flow	49.44	-70.85	-79	-95.96	-29.87
Change in Net Working Capital	-108.08	6.54	-9.89	0.1	-8.42

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q